Canadian cannabis sales are continuing to balloon amidst the coronavirus pandemic. The latest data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were up 8% from May's total sales. And during the second quarter, which ended June 30, revenue from the nationwide legal market finally finished ahead of the black market: That's the first time the licit market has come out on top since the Canadian government legalized marijuana in October 2018.
The Canadian pot market is showing more promise than ever, and two popular cannabis companies stand to benefit. Despite their historic difficulties in generating cash, paying off debts, and avoiding massive writedowns, Aphria (NASDAQ: APHA) and Aurora Cannabis (NYSE: ACB) could be poised to claim shares of the rapidly expanding marketplace. Today, I'll look at which stock is the better-positioned pick.
Aurora will release its results for the fourth quarter ended June 30 on Sept. 22 -- and it will be a pivotal moment for the company.